December 2025

Nebius AI Compute Grant Awarded to Doses AI

Doses AI has received an AI compute grant from Nebius, providing substantial H100 GPU credits for model training. The grant supports the company's research into ternary language models and on-device health AI, enabling large-scale training runs across the full Doses Mortar model lineup.

About the Grant

Nebius — the AI-focused cloud platform that emerged from Yandex's international technology division — provides GPU cloud infrastructure purpose-built for AI workloads. Their AI compute grant programme targets startups and research groups working on foundational AI problems, offering H100 GPU credits that would otherwise represent a significant capital barrier for early-stage companies.

Doses AI was selected for the grant based on its novel approach to model compression. The company's distillation pipeline converts full-precision fp16 models into 1.58-bit ternary architectures — models where every weight is constrained to just three values: {-1, 0, +1}. This extreme quantisation enables the resulting models to run on consumer smartphones, but the training process itself demands substantial GPU compute.

About Nebius

Nebius is an AI-native cloud platform providing GPU infrastructure for AI training and inference. Built on a foundation of large-scale distributed systems expertise, Nebius operates data centres equipped with Nvidia H100 clusters and offers managed ML platforms, storage, and networking optimised for AI workloads.

What the Grant Supports

The Nebius compute grant is being applied to the most compute-intensive stage of Doses AI's model development pipeline:

Grant Type
AI Compute Credits
Hardware
Nvidia H100 GPUs
Model Range
0.5B to 12B Parameters
Architecture
1.58-bit Ternary
"There's an irony in needing powerful cloud GPUs to build models that don't need the cloud. Nebius's grant removes the compute bottleneck and lets us focus on the research — finding the best path from 16-bit precision down to three values." — Malik Ahmed, Founder & CEO, Doses AI
Doses AI · 2025